Insurance companies are increasingly refusing to cover interbody device spacers used in anterior cervical discectomy and fusion (ACDF) surgeries, labeling them as experimental. This practice overrides current medical evidence and professional consensus from major spine societies. The situation highlights a broader issue of third-party payers influencing clinical decisions, raising questions about the extent of their oversight in healthcare delivery. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON This article discusses a specific issue within the healthcare industry concerning insurance coverage for medical devices, which is not a core AI development.
